We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-9.18%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$51.6B
AUM Growth
-$1.23B
Cap. Flow
+$5.12B
Cap. Flow %
9.92%
Top 10 Hldgs %
13.97%
Holding
4,098
New
840
Increased
1,320
Reduced
1,195
Closed
681

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$1.55B
2
CMCSA icon
Comcast
CMCSA
+$449M
3
SLB icon
SLB Ltd
SLB
+$298M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$281M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 11.35%
2 Energy 10.93%
3 Consumer Discretionary 8.63%
4 Financials 8.18%
5 Technology 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXGN
3801
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-368,032
Closed -$6.1M
ICPT
3802
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-15,095
Closed -$3.32M
AVID
3803
DELISTED
Avid Technology Inc
AVID
-173,603
Closed -$2.32M
PRTK
3804
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-38,286
Closed -$987K
WWE
3805
CALL
DELISTED
World Wrestling Entertainment
WWE
-200,000
Closed -$3.3M
WWE
3806
DELISTED
World Wrestling Entertainment
WWE
-70,105
Closed -$1.31M
QUOT
3807
DELISTED
Quotient Technology Inc
QUOT
-54,444
Closed -$587K
ATTO
3808
DELISTED
Atento S.A.
ATTO
-7,851
Closed -$568K
MLVF
3809
DELISTED
Malvern Bancorp, Inc.
MLVF
-10,003
Closed -$148K
ABB
3810
DELISTED
ABB Ltd
ABB
-66,032
Closed -$1.38M
CYAD
3811
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
-81,942
Closed -$4.26M
VYNT
3812
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
-87
Closed -$153K
FRC
3813
DELISTED
First Republic Bank
FRC
-95,884
Closed -$6.04M
IBA
3814
DELISTED
Industrias Bachoco SAB De C.V.
IBA
-4,446
Closed -$241K
PLXP
3815
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-4,023
Closed -$409K
SIOX
3816
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-9,322
Closed -$1.52M
CLR
3817
CALL
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-90,000
Closed -$3.81M
TWTR
3818
DELISTED
Twitter, Inc.
TWTR
-113,520
Closed -$4.11M
TGA
3819
DELISTED
Transglobe Energy Corp
TGA
-26,100
Closed -$104K
MNDT
3820
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
-100,000
Closed -$4.89M
EPZM
3821
DELISTED
Epizyme, Inc
EPZM
-50,000
Closed -$1.2M
NPTN
3822
DELISTED
NEOPHOTONICS CORP
NPTN
-553,638
Closed -$5.05M
NP
3823
DELISTED
Neenah, Inc. Common Stock
NP
-22,484
Closed -$1.33M
CERN
3824
CALL
DELISTED
Cerner Corp
CERN
-380,000
Closed -$26.2M
ATRS
3825
CALL
DELISTED
Antares Pharma, Inc.
ATRS
-233,300
Closed -$485K

Similar funds

Millennium Management's Q3 2015 Portfolio in Review

As of Q3 2015, Millennium Management held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Millennium Management deployed $5.12B of net new capital in Q3 2015, opening 840 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 14% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.

  • Millennium Management's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
  • Millennium Management added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
  • Millennium Management's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
  • Millennium Management fully exited PepsiCo in Q3 2015, selling an estimated $173M.
  • Millennium Management's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
  • Millennium Management opened 840 new positions and closed 681 in Q3 2015.
  • Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $51.6B.

Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.